Skip to main content
. 2026 Aug 24;18(17):2741. doi: 10.3390/cancers18172741
Abbreviation Full term
EC Endometrial cancer
FST Fertility-sparing treatment
G1 Grade 1
AEH Atypical endometrial hyperplasia
FIGO International Federation of Gynecology and Obstetrics
ESGO European Society of Gynaecological Oncology
ESHRE European Society of Human Reproduction and Embryology
ESGE European Society for Gynaecological Endoscopy
NCCN National Comprehensive Cancer Network
ACOG American College of Obstetricians and Gynecologists
MRI Magnetic resonance imaging
LNG-IUS Levonorgestrel-releasing intrauterine system
MPA Medroxyprogesterone acetate
MA Megestrol acetate
PCOS Polycystic ovary syndrome
GLP-1 Glucagon-like peptide-1
GLP-1RA Glucagon-like peptide-1 receptor agonist
GIP Glucose-dependent insulinotropic polypeptide
BMI Body mass index
MMRd Mismatch repair deficiency
MSI-H Microsatellite instability-high
POLEmut POLE exonuclease domain mutation
NSMP No specific molecular profile
AH Atypical hyperplasia
EIN Endometrial intraepithelial neoplasia
GnRH-a Gonadotropin-releasing hormone agonist
IGF-1 Insulin-like growth factor-1
ER Estrogen receptor
PR Progesterone receptor
PGR Progesterone receptor gene
PI3K Phosphoinositide 3-kinase
AKT Protein kinase B
AMPK AMP-activated protein kinase
mTOR Mechanistic target of rapamycin
MAPK Mitogen-activated protein kinase
IL-6 Interleukin-6
TNF-α Tumor necrosis factor-α
NF-κB Nuclear factor κB
STAT3 Signal transducer and activator of transcription 3
DHCR24 24-Dehydrocholesterol reductase
MMR Mismatch repair
PD-1 Programmed cell death protein 1
PD-L1 Programmed death-ligand 1
CR Complete response
ART Assisted reproductive technology
MDT Multidisciplinary team
RFS Recurrence-free survival
AI Artificial intelligence
AUC Area under the receiver operating characteristic curve